Advertisements


Axsome reports Duke University completed analysis of Phase 2 trial of AXS-05

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 15th, 2019

Mallinckrodt reports retrospective analysis on Phase 3 REVERSE trial data at ILC

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 15th, 2019

Oragenics reports interim safety analysis results from Phase 2 AG013 trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 30th, 2018

Surface Oncology Reports Financial Results and Corporate Highlights for First Quarter 2018

Initiated a Phase 1 trial of SRF231, a fully human antibody targeting CD47 Completed upsized initial public offering and concurrent private placement raising a t.....»»

Category: earningsSource: benzingaMay 29th, 2018

Opko Health reports additional results from Phase 2 OPK-88003 trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 12th, 2019

AstraZeneca reports publication of Fasenra Phase 2 trial results in NEJM

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 4th, 2019

MediciNova "excited" with results of SPRINT-MS Phase 2b trial subgroup analysis

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 1st, 2019

Autolus reports initial results from ALLCAR19 Phase 1/2 trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 1st, 2019

TG Therapeutics reports data from MZL cohort of Phase 2b UNITY-NHL trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 1st, 2019

Unum Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update

- Advancing ATTCK-20-03 Phase 1 Trial in CD20+ Non-Hodgkin Lymphoma Toward Expansion Phase; Completing ATTCK-20-2 Study - - Continued.....»»

Category: earningsSource: benzingaMar 28th, 2019

PhaseBio Reports Fourth Quarter and Full-Year 2018 Financial and Business Results

Results from Phase 1 clinical trial of PB2452 published in the New England Journal of Medicine and presented at the American Col.....»»

Category: earningsSource: benzingaMar 26th, 2019

Radius presents analysis from Phase 3 ACTIVE trial, data from TYMLOS studies

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 24th, 2019

Aptinyx Reports Fourth Quarter and Full Year 2018 Financial Results and Highlights Pipeline and Business Progress

Completed Phase 2 study of NYX-2925 in painful DPN -- did not meet primary endpoint, but NYX-2925 demonstrated robust analgesic activity in a large and mechanistically relevant patient sub-group Reported positive da.....»»

Category: earningsSource: benzingaMar 21st, 2019

CEL-SCI"S Phase III Trial In Head & Neck Cancer My Analysis

CEL-SCI"S Phase III Trial In Head & Neck Cancer My Analysis.....»»

Category: topSource: seekingalphaMar 19th, 2019

Scholar Rock Reports Full Year 2018 Financial Results and Highlights Business Progress

Initiated and Progressed Phase 1 Clinical Trial of SRK-015 in Healthy Volunteers, Transitioning to a Clinical-Stage Company Presented Compelling Preclinical Data from the SRK-181 Cancer Immunotherapy Program at the Society for .....»»

Category: earningsSource: benzingaMar 18th, 2019

Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Operational Highlights

Phase 3 RECOVERY Trial of Tonmya┬« for the .....»»

Category: earningsSource: benzingaMar 18th, 2019

Biophytis Reports Annual 2018 Financial Results and Provides Operational Update

Clinical execution and advancement of our SARA program, including initiation of the SARA-INT Phase 2b clinical trial for sarcopenia Launch of our MYODA program for Duchenne muscular dy.....»»

Category: earningsSource: benzingaMar 12th, 2019

Allogene Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results

Phase 1 ALLO-501 Clinical Trial On-Track for Initiation in 1H 2019 Trial Includes Dose Escalation to Determine the Optimal Dose of ALLO-501 and Use of ALLO-647 for Lymphodepletion in Patients with Relapsed/Refractory Non-Hodgkin L.....»»

Category: earningsSource: benzingaMar 8th, 2019

Scholar Rock reports interim results from Phase 1 SRK-015 trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 26th, 2019

AstraZeneca reports Phase 3 POLO trial met primary PFS endpoint

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 26th, 2019

Actinium Pharmaceuticals reports new data from Phase 3 SIERRA trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 25th, 2019